China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

SZSE:000999 Stock Report

Market Cap: CN¥52.5b

China Resources Sanjiu Medical & Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

China Resources Sanjiu Medical & Pharmaceutical has a total shareholder equity of CN¥25.4B and total debt of CN¥2.9B, which brings its debt-to-equity ratio to 11.4%. Its total assets and total liabilities are CN¥40.7B and CN¥15.3B respectively. China Resources Sanjiu Medical & Pharmaceutical's EBIT is CN¥4.3B making its interest coverage ratio -107. It has cash and short-term investments of CN¥8.8B.

Key information

11.4%

Debt to equity ratio

CN¥2.89b

Debt

Interest coverage ratio-107x
CashCN¥8.77b
EquityCN¥25.37b
Total liabilitiesCN¥15.32b
Total assetsCN¥40.70b

Recent financial health updates

Recent updates

Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

Aug 26
Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?

Aug 09
Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?

Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Jul 12
Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50

Jun 09
China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued

Apr 16
An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued

Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Mar 20
Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?

Feb 28
Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?

Financial Position Analysis

Short Term Liabilities: 000999's short term assets (CN¥23.2B) exceed its short term liabilities (CN¥12.6B).

Long Term Liabilities: 000999's short term assets (CN¥23.2B) exceed its long term liabilities (CN¥2.7B).


Debt to Equity History and Analysis

Debt Level: 000999 has more cash than its total debt.

Reducing Debt: 000999's debt to equity ratio has increased from 0.2% to 11.4% over the past 5 years.

Debt Coverage: 000999's debt is well covered by operating cash flow (165.2%).

Interest Coverage: 000999 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies